Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunjesh Kumar Singh

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of the Egyptian National Cancer Institute|May 22, 2021
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositisVanita Noronha, Vijay M Patil, Gunjesh Kumar Singh, et al.
Ecancermedicalscience|November 4, 2020
Lymphopenia during chemoradiation-foe or friendVijay M Patil, Gunjesh Kumar Singh, Vanita Noronha, et al.
Cancer Medicine|February 16, 2021
A real-world data of Immune checkpoint inhibitors in solid tumors from IndiaVanita Noronha, George Abraham, Vijay Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2022
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized StudyVijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of the Egyptian National Cancer Institute|May 22, 2021
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositisVanita Noronha, Vijay M Patil, Gunjesh Kumar Singh, et al.
Ecancermedicalscience|November 4, 2020
Lymphopenia during chemoradiation-foe or friendVijay M Patil, Gunjesh Kumar Singh, Vanita Noronha, et al.
Cancer Medicine|February 16, 2021
A real-world data of Immune checkpoint inhibitors in solid tumors from IndiaVanita Noronha, George Abraham, Vijay Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2022
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized StudyVijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.
Pageof 2